The DOI matches its Crossref record; 64 of the 67 references it cites were found in a registry or an index.
Clinical Features of Adrenocortical Carcinoma, Prognostic Factors, and the Effect of Mitotane Therapy
Open accessAbstract
Adrenocortical carcinoma is a rare tumor, and only limited information is available about its natural history and the effects of therapy. We studied 105 patients (75 female and 30 male; mean age, 46 years) with adrenocortical carcinoma who were referred to us between 1963 and 1987. The average duration of symptoms before diagnosis was 8.7 months. At the time of diagnosis, 68 percent of the patients had endocrine symptoms, and 30 percent had distant metastases. Hormonal studies showed that 79 percent of the tumors were functional. Eighty patients underwent surgery, and 59 also received the adrenal cytotoxic agent mitotane. The median disease-free interval after surgery was 12.1 months (range, 1 to 175). Tumor dissemination occurred in 82 percent of the patients, most commonly to the lung, liver, and adjacent organs. The median survival time was 14.5 months (range, less than 1 to 175), and the five-year survival was 22 percent. Age over 40 years and the presence of metastases at the time of diagnosis were the only factors recognized as indicating a poor prognosis. Mitotane controlled hormonal secretion in 75 percent of the patients. Eight mitotane-treated patients had partial tumor regression, but the drug did not have a significant effect on survival. We conclude that adrenocortical carcinoma carries a poor prognosis. Mitotane therapy may offer transient benefits, particularly in controlling endocrine symptoms.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“This is in accordance with a median age of 46 years in a large single center series in France (10).”
From Adrenocortical carcinoma (2014) · cites this paper as [10]
In the citing paper
“In the adult as well as in the pediatric population, there is a predilection for the female gender (the ratio of female to male ranges from 1.5–2.5:1) (10, 17).”
From Adrenocortical carcinoma (2014) · cites this paper as [10]
In the citing paper
“A role of estrogens has also been suggested by the observation of a probable relative increase of diagnosis of ACC during pregnancy (10, 19).”
From Adrenocortical carcinoma (2014) · cites this paper as [10]
In the citing paper
“For 40% to 60% of patients, the major presenting complaints are symptoms and signs of hormone excess (3, 9, 10).”
From Adrenocortical carcinoma (2014) · cites this paper as [10]
In the citing paper
“Another third present with nonspecific symptoms due to local tumor growth, such as abdominal or flank pain, abdominal fullness, or early satiety (9, 10).”
From Adrenocortical carcinoma (2014) · cites this paper as [10]
In the citing paper
“Patients with ACC only rarely present with classical tumor symptoms, such as cachexia or night sweats (3, 10).”
From Adrenocortical carcinoma (2014) · cites this paper as [10]
In the citing paper
“Biochemically or clinically apparent adrenocortical hormone production is evident in up to 45% to 70% (9, 10, 85).”
From Adrenocortical carcinoma (2014) · cites this paper as [10]
In the citing paper
“Hypercortisolism is the most common presentation of patients presenting with hormone excess (50%–80% of hormone-secreting ACCs), causing classic symptoms including plethora, diabetes mellitus, muscle weakness/atrophy, and osteoporosis.”
From Adrenocortical carcinoma (2014) · cites this paper as [10]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nonparametric Estimation from Incomplete Observations
Kaplan, E. L., & Meier, P. (1992) · Springer series in statistics · doi:10.1007/978-1-4612-4380-9_25 · Cited by 45,239
Regression Models and Life-Tables
Cox, D. R. (1972) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1972.tb00899.x · Cited by 39,793
Nonparametric Estimation from Incomplete Observations
Kaplan, E. L., & Meier, P. (1958) · Journal of the American Statistical Association · doi:10.1080/01621459.1958.10501452 · Cited by 39,158
The Statistical Analysis of Failure Time Data.
Aitkin, M. A., Kalbfleisch, J. D., & Prentice, R. L. (1981) · Biometrics · doi:10.2307/2530581 · Cited by 9,875
Murphy, B. E. P. (1967) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-27-7-973 · Cited by 1,998
Incidence of malignant tumors in U.S. children
Young, J. L., & Miller, R. W. (1975) · The Journal of Pediatrics · doi:10.1016/s0022-3476(75)80484-7 · Cited by 842
On Distribution-Free Tests for Equality of Survival Distributions
Tarone, R. E., & Ware, J. S. (1977) · Biometrika · doi:10.1093/biomet/64.1.156 · Cited by 733
Byar, D. P. (1973) · Cancer · doi:10.1002/1097-0142(197311)32:5 · Cited by 595
Rubinstein, L. J., Herman, M. M., Long, T. F., & Wilbur, J. R. (1975) · Cancer · doi:10.1002/1097-0142(197502)35:2 · Cited by 383
Results of Treatment in 108 Patients with Cushing's Syndrome
Orth, D. N., & Liddle, G. W. (1971) · New England Journal of Medicine · doi:10.1056/nejm197107292850501 · Cited by 327
Research works printed but not linked: 21
- Plager, 1984, Int Adv Surg Oncol, 7, 329
- Macfarlane, 1958, Ann R Coll Surg Engl, 23, 155
- Heinbecker, 1957, Surg Gynecol Obstet, 105, 21
- Brennan, 1987, CA, 37, 348
- Bradley, 1975, Surg Gynecol Obstet, 141, 507
- Greenberg, 1978, Am Surg, 44, 81
- Ostuni, 1975, Arch Intern Med, 135, 1257, 10.1001/archinte.1975.00330090129015 · DOI
- Haq, 1980, Cancer Treat Rep, 64, 909
- Bricaire, 1977, Nouv Presse Med, 6, 3650
- Rappaport, 1978, Arch Fr Pediatr, 35, 551
- Levine, 1978, Am J Dis Child, 132, 238
- Lejonc, 1978, Nouv Presse Med, 7, 3147
- Pugeat, 1980, Ann Endocrinol, 41, 107
- Cathelineau, 1980, Ann Endocrinol, 41, 65
- Cassan, 1978, Nouv Presse Med, 7, 2153
- Benaily, 1975, Arch Fr Pediatr, 32, 441
- Cariou, 1982, Nouv Presse Med, 11, 2821
- Charbonnel, 1980, Nouv Presse Med, 9, 239
- Jarabak, 1981, JAMA, 246, 1706, 10.1001/jama.1981.03320150054033 · DOI
- Levy, 1985, Ann Pediatr (Paris), 32, 541
- du Rostu, 1987, Presse Med, 16, 951
Cited by
Sorted by citations
Items 401–500 of 712
Those excrescences on Descemet's membrane
Lietman, T. M. (2003) · British Journal of Ophthalmology · doi:10.1136/bjo.87.4.515-a · Cited by 6
The molecular genetics of adrenal cushing
Vaduva, P., & Bertherat, J. Y. (2024) · HORMONES · doi:10.1007/s42000-024-00608-0 · Cited by 5
Clinical and Histopathological Variables and Prognostic Factors of Adrenocortical Carcinoma
Sohail, S., Azmat, U., Khawaja, S. N., Mir, K., Azam, M., Syed, M., Mushtaq, S., Hassan, U., Siddiqui, A., Raza, S. A., et al. (2021) · Cureus · doi:10.7759/cureus.15721 · Cited by 5
Avascular Necrosis of Femur as a Complication of Cushing’s Syndrome Due to Adrenocortical Carcinoma
Anand, A., Jha, C. K., Singh, P. K., Sinha, U., Ganesh, A., & Bhadani, P. P. (2022) · The American Surgeon · doi:10.1177/00031348221129510 · Cited by 5
Steroid profiling in adrenal disease
Mu, D., Sun, D., Qian, X., Ma, X., Qiu, L., Cheng, X., & Yu, S. (2023) · Clinica Chimica Acta · doi:10.1016/j.cca.2023.117749 · Cited by 5
Expression Patterns of MOTS-c in Adrenal Tumors: Results from a Preliminary Study
Kamiński, K., Blatkiewicz, M., Szyszka, M., Olechnowicz, A., Komarowska, H., Klimont, A., Wierzbicki, T., Karczewski, M., Ruchała, M., & Ruciński, M. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25168721 · Cited by 6
Unusual Manifestations of Cushing’s Syndrome in A Multiple Endocrine Neoplasia Type I Kindred
Sundaram, V., Schuster, D. P., & Falko, J. M. (1998) · Endocrine Practice · doi:10.4158/ep.4.4.190 · Cited by 5
Ohashi, K., Hayashi, T., Sakamoto, M., Iuchi, H., Suzuki, H., Ebisawa, T., Tojo, K., Sasano, H., & Utsunomiya, K. (2016) · BMC Endocrine Disorders · doi:10.1186/s12902-016-0083-0 · Cited by 5
Adrenal cortical carcinoma with tumor thrombus extension into the right atrium: A case report
Wang, Y., Zhou, F., Pan, H., & Jin, B. (2016) · Oncology Letters · doi:10.3892/ol.2016.4502 · Cited by 5
Schwarte, S., Brabant, E. G., Bastian, L., & Bruns, F. (2007) · PubMed · Cited by 5
Epigenetic dysregulation in adrenocortical carcinoma, a systematic review of the literature
Jonker, P., Meyer, V., & Kruijff, S. (2017) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2017.08.009 · Cited by 5
Advances in the Diagnosis and Medical Management of Cushing's Syndrome
Delivanis, D. A., Sharma, A. R., Hamidi, O., Shah, M., & Bancos, I. (2019) · Elsevier eBooks · doi:10.1016/b978-0-323-66195-9.00015-7 · Cited by 5
Adrenal Causes of Hypercortisolism
Cavagnini, F., & Giraldi, F. P. (2010) · Elsevier eBooks · doi:10.1016/b978-1-4160-5583-9.00102-7 · Cited by 5
Naffouje, S. A., Sabesan, A. C., Johnson, J. E. H., Kirtane, K., Gonzalez, R. J., & Mullinax, J. E. (2021) · Journal of Surgical Oncology · doi:10.1002/jso.26639 · Cited by 5
The prognosis difference between elderly and younger patients with adrenocortical carcinoma
He, S., Huang, X., Zhao, P., & Zhang, P. (2023) · Frontiers in Genetics · doi:10.3389/fgene.2022.1029155 · Cited by 5
Defining Optimal Management of Non-metastatic Adrenocortical Carcinoma
Passman, J. E., Amjad, W., Ballester, J. M. S., Ginzberg, S. P., & Wachtel, H. (2023) · Annals of Surgical Oncology · doi:10.1245/s10434-023-14533-w · Cited by 6
Tumeurs sécrétantes de la corticosurrénale
Mongiat-Artus, P., Miquel, C., MERIA, P., Hernigou, A., & Duclos, J.-M. (2004) · Annales d Urologie · doi:10.1016/j.anuro.2004.05.001 · Cited by 5
Beom, S., Lee, K.-W., Yang, Y., Choi, Y., Song, K., Kim, Y. J., Kim, J. H., Bang, S., Chung, J.-H., & Lee, J. S. (2011) · Japanese Journal of Clinical Oncology · doi:10.1093/jjco/hyr144 · Cited by 5
Adrenal Causes of Cushing’s Syndrome
Cavagnini, F., & Giraldi, F. P. (2015) · Elsevier eBooks · doi:10.1016/b978-0-323-18907-1.00103-7 · Cited by 5
The role of steroid metabolome analysis for the diagnosis and follow-up of adrenocortical tumors
Chortis, V. (2018) · Minerva Endocrinology · doi:10.23736/s0391-1977.18.02869-9 · Cited by 5
The challenge to differentiate between sarcoma or adrenal carcinoma—an observational study
Dobrindt, E. M., Saeger, W., Bläker, H., Mogl, M. T., Bahra, M., Pratschke, J., & Rayes, N. (2021) · Rare Tumors · doi:10.1177/20363613211057746 · Cited by 5
Karaköse, M., Hasdemır, O., Çakal, E., & Delibaşı, T. (2013) · Journal of Medical Case Reports · doi:10.1186/1752-1947-7-200 · Cited by 5
Yanagi, Y. (2003) · British Journal of Ophthalmology · doi:10.1136/bjo.87.4.509 · Cited by 5
Adrenocortical Carcinoma Presenting with Cushing Syndrome
Sharma, N., & Herts, B. R. (2013) · The Journal of Urology · doi:10.1016/j.juro.2013.12.019 · Cited by 5
Molekularbiologie, Klinik und Therapie steroidbedingter Hypertonien
Peters, J., Hampf, M., Peters, B., & Bernhardt, R. (1998) · Springer eBooks · doi:10.1007/978-3-642-80360-4_13 · Cited by 5
The management of adrenocortical carcinoma in the era of precision medicine
Flauto, F., Ferone, G., Martino, M. C. D., Pivonello, R., Colao, A., & Damiano, V. (2025) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2025.104839 · Cited by 6
Adrenal Cortex Tumors and Hyperplasias
Pignatelli, D. (2011) · InTech eBooks · doi:10.5772/19108 · Cited by 4
Adrenocortical Carcinoma With Renal Vein Thrombus Extended to Inferior Vena Cava: A Case Report
Ayati, M., Shahbazi, J., Tehranchi, A., Ayati, E., & Rezaei, Y. (2015) · International Surgery · doi:10.9738/intsurg-d-14-00224.1 · Cited by 4
Miao, J., Wei, H., Cui, J., Zhang, Q., Liu, F., Mao, Z., & Zhang, D. (2022) · PLoS ONE · doi:10.1371/journal.pone.0264431 · Cited by 4
Extra-adrenal, non-functional adrenocortical carcinoma presenting with acute abdomen: a case report
Mirsharifi, A., Vasei, M., Sadeghian, E., Abdehgah, A. G., & Atashi, S. N. (2020) · Journal of Medical Case Reports · doi:10.1186/s13256-020-02408-7 · Cited by 4
Neuroblastoma and Other Adrenal Tumors
Christison-Lagay, E. R., & LaQuaglia, M. P. (2016) · Springer eBooks · doi:10.1007/978-3-662-48590-3_14 · Cited by 4
Cushing’s disease: current trends in treatment
Juszczak, A., & Grossman, A. B. (2013) · Clinical Practice · doi:10.2217/cpr.13.61 · Cited by 4
Inherited retinal dystrophy and asymmetric axial length
Francis, P. J. (2003) · British Journal of Ophthalmology · doi:10.1136/bjo.87.4.503 · Cited by 4
Clinical Impact of Recent Advances in the Biology of Adrenocortical Cancer
Beuschlein, F., Looyenga, B. D., Reincke, M., Giordano, T. J., & Hammer, G. D. (2003) · The Endocrinologist · doi:10.1097/01.ten.0000100240.50691.5a · Cited by 4
Dorfinger, K., Vierhapper, H., Wilfing, A., Czernin, S., Niederle, B., Nowotny, P., Peterlik, M., Waldhäust, W., & Grubeck-Loebenstein, B. (1991) · Metabolism · doi:10.1016/0026-0495(91)90123-e · Cited by 4
Sweeney, A. T., Blake, M. A., Aish, L. S., Pais, V. M., Dowling, J. J., Melby, J. C., & Tully, G. L. (2002) · Endocrine Practice · doi:10.4158/ep.8.5.373 · Cited by 4
Pulmonary Embolism as an Initial Presentation of Adrenocortical Carcinoma
Aung, S. Y. (2014) · World Journal of Oncology · doi:10.14740/wjon814w · Cited by 4
Juszczak, A., Morris, D. G., Grossman, A. B., & Nieman, L. K. (2015) · Elsevier eBooks · doi:10.1016/b978-0-323-18907-1.00013-5 · Cited by 4
Imataki, O., Makimoto, A., Kojima, R., Sakiyama, M., Hosono, A., & Takaue, Y. (2006) · International Journal of Clinical Oncology · doi:10.1007/s10147-005-0556-z · Cited by 4
Terzolo, M., Osella, G., Alı̀, A., & Angeli, A. (2000) · Endocrine updates · doi:10.1007/978-1-4615-4341-1_10 · Cited by 4
The Role of Surgery in Adrenal Cancer
Norton, J. A. (1999) · Annals of Surgical Oncology · doi:10.1007/s10434-999-0713-0 · Cited by 4
Endocrine and Metabolic Symptoms of Cancer and Its Treatment
Dev, R. (2010) · Springer eBooks · doi:10.1007/978-1-4419-1225-1_13 · Cited by 3
Rao, S. N., & Habra, M. A. (2015) · Hormones and Cancer · doi:10.1007/s12672-015-0247-9 · Cited by 3
Validated predictive model for treatment and prognosis of adrenocortical carcinoma
Zuber, S. M., Kuchta, K. M., Holoubek, S. A., Khokar, A. M., Moo‐Young, T. A., Prinz, R. A., & Winchester, D. J. (2023) · Surgery · doi:10.1016/j.surg.2023.08.047 · Cited by 3
Carcinoma da glândula supra-renal
de Freitas, A. C. T. (2007) · ABCD Arquivos Brasileiros de Cirurgia Digestiva (São Paulo) · doi:10.1590/s0102-67202007000300002 · Cited by 3
Carcinoma of unknown primary origin with isolated adrenal metastasis: a report of two cases
Kometani, M., Yoneda, T., Maeda, Y., Ohtsubo, K., Yamazaki, Y., Ikeda, H., Mori, S., Aono, D., Karashima, S., Usukura, M., et al. (2021) · Endocrine Journal · doi:10.1507/endocrj.ej21-0141 · Cited by 3
Marino, M. J., & Webster, S. M. (2023) · AACE Clinical Case Reports · doi:10.1016/j.aace.2023.03.002 · Cited by 4
Minimally Invasive Adrenalectomy and Malignant Adrenal Tumours
Nies, C., & Langer, P. (2003) · European surgery. Supplement/European surgery · doi:10.1046/j.1682-4016.2003.03028.x · Cited by 3
Frozen cucumber as a mount for processing vitreoretinal specimens
Banerjee, S. (2003) · British Journal of Ophthalmology · doi:10.1136/bjo.87.4.512 · Cited by 3
Mitotane-induced dyspnoea: an unusual side effect
Farooq, A. U., Amjad, W., Kochar, T., & Adhikari, S. (2018) · BMJ Case Reports · doi:10.1136/bcr-2018-225490 · Cited by 3
Diagnostic Role of Prostate-Specific Membrane Antigen in Adrenocortical Carcinoma
Gu, Y., Gu, W., Dou, J., Lu, Z., Ba, J., Li, J., Wang, X., Liu, H., Yang, G., Guo, Q., et al. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00226 · Cited by 3
Neuroblastoma and Other Adrenal Tumors
LaQuaglia, M. P., & Rutigliano, D. N. (2008) · Springer eBooks · doi:10.1007/978-3-540-29734-5_11 · Cited by 3
Kuhlen, M., Kunstreich, M., Lessel, L., Wudy, S. A., Holterhus, P., Vokuhl, C., Juettner, E., Roecken, C., Seitz, G., Slavetinsky, C. J., et al. (2023) · EJC Paediatric Oncology · doi:10.1016/j.ejcped.2023.100015 · Cited by 4
Unusual Visualization of an Adrenal Carcinoma on NP-59 Scintiscan
Wang, F., Chang, Y., Pan, C., Tu, D., & Won, J. G. S. (2006) · Journal of the Formosan Medical Association · doi:10.1016/s0929-6646(09)60126-1 · Cited by 3
Diseases of the Pituitary and Adrenal Gland
de Swiet, M. (2002) · doi:10.1002/9780470752371.ch13 · Cited by 3
Comment on Carney Complex and Related Syndromes and their Genetic Loci
Cetta, F. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.4.5625-7 · Cited by 3
Vaughan, E. D., & Colt, J. J. (2004) · The Scientific World JOURNAL · doi:10.1100/tsw.2004.91 · Cited by 3
Hikichi, T. (2003) · British Journal of Ophthalmology · doi:10.1136/bjo.87.4.506 · Cited by 3
Murvelashvili, N., Polanco, P. M., Khorsand, S., Marrero, J. A., Jia, L., Mirfakhraee, S., Else, T., Habra, M. A., Cole, S., & Hamidi, O. (2022) · Journal of the Endocrine Society · doi:10.1210/jendso/bvac101 · Cited by 3
Imaging of Adrenocortical Carcinoma: An Update
Howard, B., Elsayed, A., Klimkowski, S., Lee, J. T., & Elsayes, K. M. (2024) · Seminars in Roentgenology · doi:10.1053/j.ro.2024.11.005 · Cited by 2
Contemporary Approaches to Adrenocortical Carcinoma
Hughes, A. J., McDow, A. D., Ritter, H. E., & Yang, A. D. (2025) · Hematology/Oncology Clinics of North America · doi:10.1016/j.hoc.2025.07.003 · Cited by 2
Functional Imaging of Adrenocortical Carcinoma
Avram, A. M., & Hahner, S. (2009) · Springer eBooks · doi:10.1007/978-0-387-77236-3_7 · Cited by 2
Moussa, Y., Moussa, M., & Chakra, M. A. (2019) · International Journal of Surgery Case Reports · doi:10.1016/j.ijscr.2019.12.028 · Cited by 2
Adrenocortical Carcinoma: A Case of Missed Diagnosis
Hazimeh, Y., Sigel, C., Carie, C., Leinung, M., & Khalaf, Z. (2021) · Cureus · doi:10.7759/cureus.14235 · Cited by 2
Cushing Syndrome due to Adrenocortical Carcinoma During Pregnancy
Morris, J., Campbell, P. R., Xu, L., & O’Sullivan, A. (2023) · JCEM Case Reports · doi:10.1210/jcemcr/luad118 · Cited by 2
Contemporary Approaches to Adrenocortical Carcinoma
Hughes, A. J., McDow, A. D., Ritter, H. E., & Yang, A. D. (2024) · Advances in Oncology · doi:10.1016/j.yao.2024.11.003 · Cited by 2
Pfeffer, A., Beke, N., Bakó, D., Hernádfői, M., Kói, T., Fogarasi, A., Párniczky, A., Hegyi, P. J., & Garami, M. (2025) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaf457 · Cited by 2
Clinical Case of Metastatic Adrenocortical Carcinoma With Unusual Evolution: Review the Literature
Cabezón‐Gutiérrez, L., Franco‐Moreno, A., Khosravi‐Shahi, P., Custodio‐Cabello, S., Navarro, M. J. G., & Martin-Diaz, R. M. (2015) · World Journal of Oncology · doi:10.14740/wjon936w · Cited by 2
Primary Adrenocortical Carcinoma
Proye, C. A. G., Pattou, F. N., & Armstrong, J. (2005) · Springer eBooks · doi:10.1007/3-540-26861-8_13 · Cited by 2
Intensive Chemotherapy With Autologous PBSCT for Advanced Adrenocortical Carcinoma in a Child
Hah, J. O. (2008) · Journal of Pediatric Hematology/Oncology · doi:10.1097/mph.0b013e3181647c03 · Cited by 2
Ozawa, W., Sato, K., Miyakoshi, T., Nishio, S., Yamazaki, M., Suzuki, S., & Komatsu, M. (2013) · Geriatrics and gerontology international/Geriatrics & gerontology international · doi:10.1111/ggi.12027 · Cited by 2
A Case Report of Bilateral Adrenocortical Carcinoma Complicated by Adrenal Insufficiency
Kim, M. J., Kim, J. H., Kim, T. Y., & Kim, S. W. (2011) · Endocrinology and Metabolism · doi:10.3803/enm.2011.26.3.243 · Cited by 2
Diversidad en la expresión clínica del carcinoma suprarrenal. Presentación de 7 casos
MEDIAVILLA, J., Torre, M. L. D. L., Muñoz, J. Á., Sánchez, M., & Jaén, F. (2004) · Endocrinología y Nutrición · doi:10.1016/s1575-0922(04)74646-x · Cited by 2
Tratamiento terapéutico del carcinoma de la corteza suprarrenal
Albero, R., Sanz, A., Trincado, P., & Monreal, M. (2006) · Endocrinología y Nutrición · doi:10.1016/s1575-0922(06)71132-9 · Cited by 2
Tabarin, A., Collet, D., Galli, F. S., Maire, J., & Loiseau, H. (2006) · EMC - Endocrinologie - Nutrition · doi:10.1016/s1155-1941(06)40170-0 · Cited by 2
Adrenocortical Carcinoma Treated by CyberKnife
Harada, Y., & Miyazaki, S. (2016) · Internal Medicine · doi:10.2169/internalmedicine.55.6335 · Cited by 2
BERTAGNA, X. Y., Guignat, L., Raux-Demay, M. C., Guilhaume, B., & Girard, F. (2010) · Elsevier eBooks · doi:10.1016/b978-0-12-380926-1.10016-1 · Cited by 2
Self-citationWeiss, L. M., & Lau, S. K. (2009) · Elsevier eBooks · doi:10.1016/b978-1-4160-3966-2.00045-x · Cited by 2
Radiation Therapy for Adrenocortical Carcinoma
Sabolch, A. N., & Ben‐Josef, E. (2009) · Springer eBooks · doi:10.1007/978-0-387-77236-3_25 · Cited by 2
Chen, Q., Ren, Z., Liu, D., Jin, Z., Wang, X., Zhang, R., Liu, Q., & Cheng, W. (2021) · Medicine · doi:10.1097/md.0000000000027864 · Cited by 2
Rah, C.-S., Cho, J. W., Kim, W. W., Lee, Y., Chung, K., Koh, J., Lee, S. H., Lee, J., Song, D. E., Hong, S. J., et al. (2022) · Gland Surgery · doi:10.21037/gs-22-274 · Cited by 2
Hickey, K., Shakir, A., Shepherd, C., Djang, R., & Patel, S. (2022) · Indian Journal of Urology · doi:10.4103/iju.iju_77_22 · Cited by 2
The History of Adrenocortical Carcinoma Treatment – A Surgical Perspective
Thompson, N. W. (2009) · Springer eBooks · doi:10.1007/978-0-387-77236-3_2 · Cited by 2
Metástasis ósea como primera manifestación de un carcinoma suprarrenal
Vázquez, A. B., Yagüe, E. G., Solans, R., & Vilardell, M. (2001) · Medicina Clínica · doi:10.1016/s0025-7753(01)71725-3 · Cited by 2
A CASE OF ADRENOCORTICAL CARCINOMA AS AN INCIDENTALOMA
Ito, Y., HASEGAWA, S., Hoshi, S., OHSHIMA, H., KAJIWARA, S., & Sasaki, K. (2004) · Nihon Rinsho Geka Gakkai Zasshi (Journal of Japan Surgical Association) · doi:10.3919/jjsa.65.514 · Cited by 2
Handler, J. (2003) · Journal of Clinical Hypertension · doi:10.1111/j.1524-6175.2003.02833.x · Cited by 2
Almuallem, S., Abualhamael, S. A., Hala, M., Hisham, M., & Murad, A. (2018) · International Archives of Urology and Complications · doi:10.23937/2469-5742/1510048 · Cited by 2
Bragayrac, L. A. N., & Schwaab, T. (2019) · Springer eBooks · doi:10.1007/978-3-319-42603-7_41-1 · Cited by 2
Pereira, R. M. (2006) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) · Cited by 2
Cushing’s Syndrome Due to Adrenal Disorders
Blevins, L. S. (2002) · Springer eBooks · doi:10.1007/978-1-4615-1103-8_9 · Cited by 2
Carcinoma suprarrenocortical. Abordaje terapéutico en estadio avanzado
Muñoz‐Casares, F. C., López‐Cillero, P., Briceño‐Delgado, J., Ruiz, F. J. P., Gomez-Alvarez, M., Rioja‐Torres, P., Cortijo, A. A., Díaz-Iglesias, C., Rufián‐Peña, S., Solórzano-Peck, G., et al. (2002) · Cirugía Española · doi:10.1016/s0009-739x(02)72004-6 · Cited by 2
Hayes, F. J., & Eichhorn, J. H. (2000) · New England Journal of Medicine · doi:10.1056/nejm200004203421608 · Cited by 2
Amsellem, P. M., Schaer, M., & Farese, J. P. (2012) · doi:10.1002/9781118997505.ch5 · Cited by 2
Creemers, S. G., Hofland, L. J., & Feelders, R. A. (2016) · Springer eBooks · doi:10.1007/978-3-319-44136-8_12 · Cited by 2
Cellular and Molecular Pathology of Adrenocortical Carcinoma
Else, T. (2009) · Springer eBooks · doi:10.1007/978-0-387-77236-3_9 · Cited by 1
Chan, M. W.-L., Ng, C., Ngai, H., & Au, W. Y. (2021) · Surgical Practice · doi:10.1111/1744-1633.12482 · Cited by 1
Gonadotrophin-independent Precocious Puberty Secondary to an Estrogen Secreting Adrenal Tumor
Tseretopoulou, X., Murray, M. J., Buck, J., Hook, C. E., Jackson, C., Kosmoliaptsis, V., Hughes, J., Gorman, S., & Williams, R. M. (2021) · Journal of Pediatric Hematology/Oncology · doi:10.1097/mph.0000000000002208 · Cited by 1
Retroperitoneal Venous Diseases
González, J., & Ciancio, G. (2015) · Springer eBooks · doi:10.1007/978-3-642-37078-6_151 · Cited by 1
Adjuvant Radiotherapy After Surgical Resection Improves Local Control in Adrenocortical Carcinoma
Zhu, J., Yan, R., Shen, J., Miao, Z., Shen, J., Hu, K., & Zhang, F. (2024) · Asia-Pacific Journal of Clinical Oncology · doi:10.1111/ajco.14137 · Cited by 1
Metadata
- Authors
- Luton, J.-P., Cerdas, S., Billaud, L., Thomas, G., Guilhaume, B., Bertagna, X., Laudat, M.-H., Louvel, A., Chapuis, Y., Blondeau, P., Bonnin, A., & Bricaire, H.
- Affiliations
- Hôpital Cochin (FR)
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 1990-04-26
- Volume
- 322
- Issue
- 17
- Pages
- 1195-1201
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2336089418
- Cited by
- 717
- References
- 67
- Citations by year
- 2026: 8 · 2025: 8 · 2024: 15 · 2023: 26 · 2022: 22 · 2021: 31 · 2020: 20 · 2019: 17 · 2018: 23 · 2017: 16 · 2016: 19 · 2015: 27 · 2014: 25 · 2013: 19 · 2012: 31
- FWCI
- 12.17
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Surgery › Adrenal and Paraganglionic Tumors
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Health Sciences › Medicine › Oncology › Neuroendocrine Tumor Research Advances
- Keywords
- adrenocortical carcinoma, mitotane, prognostic factors, adrenal surgery, metastasis, survival, endocrine symptoms, tumor regression, adrenocortical function, age over 40
- MeSH terms
- Adrenal Cortex Hormones, Adrenal Cortex Neoplasms, Combined Modality Therapy, Female, Follow-Up Studies, Humans, Male, Middle Aged, Mitotane, Neoplasm Metastasis, Prognosis, Retrospective Studies, Survival Rate
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
